The SSX family of cancer-testis antigens as target proteins for tumor therapy.
about
Reversible disruption of mSWI/SNF (BAF) complexes by the SS18-SSX oncogenic fusion in synovial sarcomaGenetically modified T cells for the treatment of malignant diseaseT-cell mediated anti-tumor immunity after photodynamic therapy: why does it not always work and how can we improve it?Rational combinations of immunotherapeutics that target discrete pathways.DNA vaccines encoding altered peptide ligands for SSX2 enhance epitope-specific CD8+ T-cell immune responsesExpression of cancer-testis antigens MAGEA1, MAGEA3, ACRBP, PRAME, SSX2, and CTAG2 in myxoid and round cell liposarcoma.Truncated SSX protein suppresses synovial sarcoma cell proliferation by inhibiting the localization of SS18-SSX fusion protein.Expression patterns of cancer-testis antigens in human embryonic stem cells and their cell derivatives indicate lineage tracksCancer/testis (CT) antigens, carcinogenesis and spermatogenesis.Vaccination using peptides spanning the SYT-SSX tumor-specific translocationExpression of New York esophageal squamous cell carcinoma-1 in primary and metastatic melanoma.Inducible expression of cancer-testis antigens in human prostate cancer.New targets for the immunotherapy of colon cancer-does reactive disease hold the answer?Adoptive immunotherapy for cancer.Synovial sarcoma is a gateway to the role of chromatin remodeling in cancer.SSX2 regulates focal adhesion but does not drive the epithelial to mesenchymal transition in prostate cancer.PD-1 or PD-L1 Blockade Restores Antitumor Efficacy Following SSX2 Epitope-Modified DNA Vaccine ImmunizationExpression of cancer-testis antigen in multiple myeloma.Subnuclear distribution of SSX regulates its function.Cross-analysis of gene and miRNA genome-wide expression profiles in human fibroblasts at different stages of transformation.Nicotinic acetylcholine receptors induce c-Kit ligand/Stem Cell Factor and promote stemness in an ARRB1/ β-arrestin-1 dependent manner in NSCLC.Tumor-associated antigens for specific immunotherapy of prostate cancerPhotodynamic therapy of murine mastocytoma induces specific immune responses against the cancer/testis antigen P1A.Multicellular tumor spheroids of human uveal melanoma induce genes associated with anoikis resistance, lipogenesis, and SSXs.Vaccination with High-Affinity Epitopes Impairs Antitumor Efficacy by Increasing PD-1 Expression on CD8+ T Cells.Identification of novel tumour-associated antigens in canine mammary gland tumour.Human Leukocyte Antigen-A Allele Distribution in Nasopharyngeal Carcinoma Patients Showing Anti-Melanoma-Associated Antigen A or Synovial Sarcoma X-2 T Cell Response in Blood.
P2860
Q24337483-34A784D8-9AED-46FA-B709-F8B5D4B77C10Q26860657-20DA1468-08AF-45FA-AAED-DFCDAD7F4E4FQ27335110-4E8FDE85-C550-4D0A-ACCC-53BEE8BE36DBQ33606144-A48838D5-DC30-420B-AD5A-E2A7890CC21FQ34127323-EBBEE4CF-5A5F-443F-9CCD-4A700D2EC57CQ34870799-4E4FBD75-0BA3-4810-9BAA-6BD1447B4D54Q35018901-D1000F1C-46A7-4889-A201-B5E0764251D3Q35116913-AB282A36-8DCF-40CF-A9CA-2F654FDC1D4BQ35733359-372B2307-F7AF-4A5C-81FA-9A5EF20C39E1Q36565705-3471A064-A2A0-40ED-81F8-57B34AE39B7EQ37625469-3D61F629-0533-4B1B-92A5-7A97DB237093Q37686238-2445D372-0AF0-4DEA-AA5E-BE4AD7C794CCQ38089480-D4DB1D36-1C20-42F9-AB8C-BF8581C3E5C4Q38170496-FD1AC724-C449-463F-8223-381BB7FCA6B5Q38567366-9A50F9E5-5CD0-4BB8-9A5A-FA529E74DAE0Q38856316-9757A37B-3698-4C1A-928D-39B18D62E501Q38867768-F6DDF2EC-29AA-43B3-AD02-11B2B7D33E87Q39006726-15341521-1E19-458C-B9D3-DA963F62E621Q39149910-9149BD4A-F424-48EE-864D-E91193F49718Q40963795-7888D315-69C3-4607-8665-3580BEDA7220Q41919001-815B4C52-37E3-4110-836A-152D872C9586Q41977894-C5FF8733-62CF-4BA1-8AFA-5688E959B2E4Q42134929-5F1638C4-F21F-46AB-BCE8-1CD0950324D6Q42372781-239BC77E-E956-43CC-81A2-969357A727ABQ50222492-354DAE84-1C01-4EE9-838D-9B31C273D5C6Q51261122-AA05438D-C75D-440D-9601-AA8968317CF6Q55364522-F4B95A4A-C323-4C7E-8EC1-F7D21C929C4C
P2860
The SSX family of cancer-testis antigens as target proteins for tumor therapy.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The SSX family of cancer-testis antigens as target proteins for tumor therapy.
@ast
The SSX family of cancer-testis antigens as target proteins for tumor therapy.
@en
The SSX family of cancer-testis antigens as target proteins for tumor therapy.
@nl
type
label
The SSX family of cancer-testis antigens as target proteins for tumor therapy.
@ast
The SSX family of cancer-testis antigens as target proteins for tumor therapy.
@en
The SSX family of cancer-testis antigens as target proteins for tumor therapy.
@nl
prefLabel
The SSX family of cancer-testis antigens as target proteins for tumor therapy.
@ast
The SSX family of cancer-testis antigens as target proteins for tumor therapy.
@en
The SSX family of cancer-testis antigens as target proteins for tumor therapy.
@nl
P2860
P921
P356
P1476
The SSX family of cancer-testis antigens as target proteins for tumor therapy.
@en
P2093
Douglas G McNeel
Heath A Smith
P2860
P304
P356
10.1155/2010/150591
P5008
P577
2010-10-11T00:00:00Z